from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1973/-

LFCtreatmentdescriptionclass of inhibitor

0.382

Amikacinug/mL Amikacintranslation

0.257

Cap5-10ug/mL Capreomycintranslation

-0.105

Rox10-50 ug/mL Roxithromycintranslation

-0.601

SM2-5 ug/mL Streptomycintranslation

1.594

Tet5-10 ug/mL Tetracyclinetranslation

0.487

Rif0.2-5ug/mL Rifampicintranscription

-0.080

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.391

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.560

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.408

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.007

Clofazimine10-13 ug/mL Clofaziminerespiration

0.226

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.084

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.947

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.380

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.906

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.737

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.341

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.059

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.720

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.047

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.116

Nigericin50 uM Nigericinrespiration

0.056

TRC10-150 ug/mL Triclosanrespiration

-0.981

TRZ10-25 ug/mL Thioridazinerespiration

-0.647

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.198

menadione6-10 ug/mL Menadionerespiration

-0.688

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.087

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.402

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.029

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.637

NRP_1Non-replicating persistence stage 1dosRassociated

-0.113

Amp0.2mg/mL AmpicillincellWall

-0.069

Cephalexin20-100 ug/mL CephalexincellWall

1.313

Cerulenin0.32-5 ug/mL CerulenincellWall

0.388

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.181

EMB10-20 ug/mL EthambutolcellWall

-0.164

Eta12-40 ug/mL EthionamidecellWall

-0.057

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.110

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.435

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.615

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.268

BZA0.12 mg/mL BenzamidearomaticAmides

-0.164

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.305

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.217

H2O24 mM hydrogen peroxideDNAdamaging

0.174

Levo10 ug/mL LevofloxacinDNAdamaging

-0.187

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.529

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.076

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.022

UVUV-irradiationDNAdamaging

-0.440

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.202

Antimycin12.5-50 ug/mL Antimycin A?

-0.110

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.743

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.427

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.356

PA8240.2-2 ug/mL PA-824?

-0.680

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.369

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.092

Verapamil50 uM Verapamil?

-0.290

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.819

methoxatin10-20 ug/mL Methoxatin?